Date | Time | Source | Headline | Symbol | Company |
05/22/2024 | 1:40AM | PR Newswire (US) | COMPUTEX 2024 Preview | Embracing the Era of High-Capacity SSDs | | |
05/22/2024 | 1:38AM | GlobeNewswire Inc. | Novaturas Group earned EUR 34.5 mln. in the first quarter | | |
05/22/2024 | 1:33AM | Alliance News | GET READY: British Land, Close Brothers, M&S, RS, SSE at 0700 BST | | |
05/22/2024 | 1:31AM | Alliance News | Alliance News UK - start of day | | |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Aalberts N.V.: Aalberts sustained added value margin in challenging market environment | LSE:AALB | Aalberts |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Aalberts N.V.: Aalberts sustained added value margin in challenging market environment | EU:AALB | Aalberts NV |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases | EU:OSE | OSE Immunotherapeutics |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases | LSE:0RAD | Ose Immunotherapeutics Sa |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Aalberts N.V.: Aalberts sustained added value margin in challenging market environment | EU:AALB | Aalberts NV |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases | TG:6OP | OSE Immunotherapeutics |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques | EU:OSE | OSE Immunotherapeutics |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases | EU:OSE | OSE Immunotherapeutics |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques | LSE:0RAD | Ose Immunotherapeutics Sa |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Aalberts N.V.: Aalberts sustained added value margin in challenging market environment | TG:AACA | Aalberts NV |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques | TG:6OP | OSE Immunotherapeutics |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | EU:BGHL | Boussard And Gavaudan Holding Limited |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Nextensa offers its shareholders an optional dividend | EU:NEXTA | Nextensa SA |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | LSE:BGHL | Boussard & Gavaudan Holding Limited |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | LSE:BGHS | Boussard & Gavaudan Holding Limited |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Nextensa propose à ses actionnaires un dividende optionnel | LSE:0NUT | Nextensa |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Nextensa offers its shareholders an optional dividend | LSE:0NUT | Nextensa |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | EU:BGHS | Boussard and Gavaudan Holding |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Nextensa propose à ses actionnaires un dividende optionnel | EU:NEXTA | Nextensa SA |
05/22/2024 | 1:30AM | GlobeNewswire Inc. | Transaction in Own Shares | TG:6E2 | Endeavour Mining Corp |
05/22/2024 | 1:25AM | GlobeNewswire Inc. | Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, Belgium | NYSE:BHP | BHP Group Limited |
05/22/2024 | 1:16AM | Business Wire | HAFNIA LIMITED: Ex-Dividend USD 0.3443 Today | NYSE:HAFN | Hafnia Ltd |
05/22/2024 | 1:06AM | Alliance News | Japan's trade deficit widens in April, as export growth falls short | | |
05/22/2024 | 1:05AM | Business Wire | Key Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO) | NYSE:CLCO | Cool Company LTD |
05/22/2024 | 1:00AM | Business Wire | Wolters Kluwer lance Twinfield DossierFlow aux Pays-Bas, pour aider les comptables à rationaliser la collecte d'informations sur les clients | | |
05/22/2024 | 1:00AM | GlobeNewswire Inc. | Start of Day Message | | |